Ito Takamichi 伊東孝通

Researcher Number	40632964
Other IDs
Affiliation (Current)	2026: 九州大学, 医学研究院, 共同研究員
Affiliation (based on the past Project Information) *help	2025: 九州大学, 大学病院, 共同研究員 2019 – 2024: 九州大学, 大学病院, 講師
Review Section/Research Field	Principal Investigator Basic Section 53050:Dermatology-related / Basic Section 50010:Tumor biology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator がん化学療法 / がん幹細胞 / 抗体薬物複合体 / 希少がん / 皮膚がん / antibody drug conjugate / 皮膚悪性腫瘍 / 有棘細胞癌 / OVOL2 / OVOL1 / 有棘細胞がん / OVOL

Extracellular trap and ATP signaling in skin cancerPrincipal Investigator
- Principal Investigator
  
  伊東孝通
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Kyushu University
Exploring novel treatments for rare skin cancers focusing on cancer stem cellsPrincipal Investigator
- Principal Investigator
  
  Ito Takamichi
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kyushu University
The role of OVOL in the tumor progression in cutaneous SCCPrincipal Investigator
- Principal Investigator
  
  Ito Takamichi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kyushu University

All 2025 2024 2023 2020

All Journal Article Presentation

[Journal Article] A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan2025
- Author(s)
  Ito Takamichi、Tanaka Yuka、Ogata Dai、Nishida Haruto、Shiomi Tatsushi、Tanaka Ryo、Kawaguchi Aya、Miyashita Azusa、Fukushima Satoshi、Shojiguchi Naoko、Goto Hiroyuki、Togawa Yaei、Kiyohara Takahiro、Oda Yoshinao、Nakahara Takeshi
- Journal Title
  
  Scientific Reports
  
  Volume: 15 Issue: 1 Pages: 409-409
- DOI
  10.1038/s41598-024-84566-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543, KAKENHI-PROJECT-22K16283
[Journal Article] FOXM1: a new therapeutic target of extramammary Paget disease2024
- Author(s)
  Ito Takamichi、Tanaka Yuka、Kaku-Ito Yumiko、Oda Yoshinao、Nakahara Takeshi
- Journal Title
  
  Scientific Reports
  
  Volume: 14 Issue: 1 Pages: 0-0
- DOI
  10.1038/s41598-024-54773-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543
[Journal Article] TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis2024
- Author(s)
  Tanegashima Keiko、Tanaka Yuka、Ito Takamichi、Oda Yoshinao、Nakahara Takeshi
- Journal Title
  
  Experimental Dermatology
  
  Volume: 33 Issue: 10
- DOI
  10.1111/exd.15196
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543, KAKENHI-PROJECT-22K16283
[Journal Article] NECTIN4‐targeted antibody?drug conjugate is a potential therapeutic option for extramammary Paget disease2024
- Author(s)
  Tanaka Yuka、Ito Takamichi、Murata Maho、Tanegashima Keiko、Kaku‐Ito Yumiko、Nakahara Takeshi
- Journal Title
  
  Experimental Dermatology
  
  Volume: 33 Issue: 3 Pages: 0-0
- DOI
  10.1111/exd.15049
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543, KAKENHI-PROJECT-22K16283
[Journal Article] Nail Apparatus Melanoma: Current Management and Future Perspectives2023
- Author(s)
  Ito Takamichi、Hashimoto Hiroki、Kaku-Ito Yumiko、Tanaka Yuka、Nakahara Takeshi
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 12 Issue: 6 Pages: 2203-2203
- DOI
  10.3390/jcm12062203
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543
[Journal Article] Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma2023
- Author(s)
  Tanaka Yuka、Ito Takamichi、Kaku-Ito Yumiko、Tanegashima Keiko、Tsuji Gaku、Kido-Nakahara Makiko、Oda Yoshinao、Nakahara Takeshi
- Journal Title
  
  Cell Death Discovery
  
  Volume: 9 Issue: 1 Pages: 0-0
- DOI
  10.1038/s41420-023-01358-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16283, KAKENHI-PROJECT-22K15543
[Journal Article] KS-EMPD-1: a novel cell line of primary extramammary Paget’s disease2023
- Author(s)
  Ito Takamichi、Tanaka Yuka、Ichiki Toshio、Kaku-Ito Yumiko、Nakahara Takeshi
- Journal Title
  
  Human Cell
  
  Volume: 36 Issue: 5 Pages: 1813-1829
- DOI
  10.1007/s13577-023-00951-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543
[Journal Article] A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in Japan2023
- Author(s)
  Ito Takamichi、Kaku-Ito Yumiko、Ohno Fumitaka、Nakahara Takeshi
- Journal Title
  
  Frontiers in Medicine
  
  Volume: 10 Pages: 0-0
- DOI
  10.3389/fmed.2023.1293397
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15543
[Journal Article] OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma2020
- Author(s)
  Maho Murata, Takamichi Ito, Yuka Tanaka, Kazuhiko Yamamura, Kazuhisa Furue and Masutaka Furue
- Journal Title
  
  J Clin Med
  
  Volume: 9 Issue: 3 Pages: 618-618
- DOI
  10.3390/jcm9030618
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K16867
[Presentation] KS-EMPD-1: A novel cell line of extramammary Paget disease.2024
- Author(s)
  Ito T, Tanaka Y, Ichiki T, Kaku-Ito Y, Nakahara T
- Organizer
  The 123rd Annual Meeting of Japanese Dermatological Association 2024/06/6-9 Kyoto, Japan
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] Trophoblast cell surface antigen 2 (TROP2): A potential therapeutic target for extramammary Paget disease2024
- Author(s)
  Takamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, Takeshi Nakahara
- Organizer
  The 14th Meeting of the German-Japanese Society of Dermatology. Gotemba, Japan, 2024/06/26-30
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] Human epidermal growth factor receptor 3 regulates anchorage-independent growth of acral melanoma cells and serves as a novel therapeutic target.2023
- Author(s)
  Tanaka Y, Ito T, Tanegashima K, Kido-Nakahara M, Nakahara T.
- Organizer
  The 1st International Societies for Investigative Dermatology Meeting, 2023/5/11, Tokyo, Japan
- Invited
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] 血管肉腫まるごとアップデート2023
- Author(s)
  伊東孝通
- Organizer
  第39回日本皮膚悪性腫瘍学会学術大会　2023/08/04-05　名古屋市
- Invited
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] 教育講演皮膚科医が診る軟部肉腫の治療2023
- Author(s)
  伊東孝通
- Organizer
  第122回日本皮膚科学会総会 2023/06/01-04　横浜市
- Invited
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] Nail apparatus melanoma: Current management and future perspectives.2023
- Author(s)
  Ito T.
- Organizer
  The 8th Annual Meeting of Korean Nail Society. 2023/10/14. Seoul, Korea
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] [Symposium] Pleomorphic sarcomas and other rare mesenchymal tumors: diagnosis and treatment.2023
- Author(s)
  Ito T, Nakahara T.
- Organizer
  The 25th World Congress of Dermatology 2023/07/06 Singapore
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] 教育講演　皮膚科医が診る軟部肉腫の治療2023
- Author(s)
  伊東孝通
- Organizer
  第122回日本皮膚科学会総会 2023/06/01-04　横浜市
- Invited
- Data Source
  KAKENHI-PROJECT-22K15543
[Presentation] 皮膚希少がんに対する抗体薬物複合体の可能性2023
- Author(s)
  伊東裕美子、伊東孝通、田中由香、種子島桂子、村田真帆、橋本弘規、中原剛士
- Organizer
  第39回日本皮膚悪性腫瘍学会学術大会　2023/08/04-05　名古屋市
- Data Source
  KAKENHI-PROJECT-22K15543

1. 田中由香

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ito Takamichi 伊東 孝通

Research Projects

Research Products

Co-Researchers

Extracellular trap and ATP signaling in skin cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploring novel treatments for rare skin cancers focusing on cancer stem cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The role of OVOL in the tumor progression in cutaneous SCCPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] FOXM1: a new therapeutic target of extramammary Paget disease2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NECTIN4‐targeted antibody?drug conjugate is a potential therapeutic option for extramammary Paget disease2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nail Apparatus Melanoma: Current Management and Future Perspectives2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] KS-EMPD-1: a novel cell line of primary extramammary Paget’s disease2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in Japan2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] KS-EMPD-1: A novel cell line of extramammary Paget disease.2024

Author(s)

Organizer

Data Source

[Presentation] Trophoblast cell surface antigen 2 (TROP2): A potential therapeutic target for extramammary Paget disease2024

Author(s)

Organizer

Data Source

[Presentation] Human epidermal growth factor receptor 3 regulates anchorage-independent growth of acral melanoma cells and serves as a novel therapeutic target.2023

Author(s)

Organizer

Data Source

[Presentation] 血管肉腫まるごとアップデート2023

Ito Takamichi 伊東孝通

[Presentation] 教育講演皮膚科医が診る軟部肉腫の治療2023

[Presentation] 教育講演　皮膚科医が診る軟部肉腫の治療2023